Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7153510 Recombinant vesiculoviruses and their uses

Patent 7153510 was granted and assigned to Yale University on December, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Yale University
Yale University
Date Filed
May 4, 1995
Date of Patent
December 26, 2006
Patent Application Number
08435032
Patent Citations Received
‌
US Patent 12110339 ICOS ligand variant immunomodulatory proteins and uses thereof
0
‌
US Patent 12012600 Engineered immunostimulatory bacterial strains and uses thereof
0
‌
US Patent 12024709 Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment
0
‌
US Patent 12065476 PD-1 variant immunomodulatory proteins and uses thereof
0
‌
US Patent 11655455 Enhanced systems for cell-mediated oncolytic viral therapy
0
‌
US Patent 11834490 CD112 variant immunomodulatory proteins and uses thereof
0
‌
US Patent 11920156 Engineered natural killer (NK) cells and compositions and methods thereof
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7153510
Patent Primary Examiner
‌
Bruce R. Campell

Find more entities like US Patent 7153510 Recombinant vesiculoviruses and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.